Literature DB >> 15293958

[The use of anxiolytic and hypnotic drugs in Spain (1995-2002)].

Javier García del Pozo1, Francisco J de Abajo Iglesias, Alfonso Carvajal García-Pando, Dolores Montero Corominas, Mariano Madurga Sanz, Victorina García del Pozo.   

Abstract

BACKGROUND: Recent studies have revealed a rise in the use of anxiolytic and hypnotic drugs as well as the improper use thereof in Western countries. This study is aimed at ascertaining the pattern of use of anxiolytic and hypnotic drugs in Spain within the 1995-2002 period.
METHODS: The data related to the use of medications was taken from the Ministry of Health and Consumer Affairs' ECOM (Medicinal Products Consumption) database, which includes information on the use of medications delivered through the community pharmacies and reimbursed by the National Health System. The data are expressed in Defined Daily Doses per 1,000 inhabitants per day.
RESULTS: The use of anxiolytic and hypnotic drugs rose from 39.71 Defined Daily Doses per 1,000 inhabitants per day in 1995 to 62.02 in 2002. Throughout the period under study, benzodiazepines having a medium-range half-life (8-24 h.) were those most used, especially lorazepam, alprazolam and lormetazepam. The active ingredient having shown the greatest drop in use was flunitrazepam.
CONCLUSIONS: Although the use of anxiolytic and hypnotic drugs has undergone a considerable rise in recent years in Spain, the pattern of use has shown no major changes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15293958     DOI: 10.1590/s1135-57272004000300007

Source DB:  PubMed          Journal:  Rev Esp Salud Publica        ISSN: 1135-5727


  3 in total

1.  Comparative efficacy of two primary care interventions to assist withdrawal from long term benzodiazepine use: a protocol for a clustered, randomized clinical trial.

Authors:  Caterina Vicens; Isabel Socias; Catalina Mateu; Alfonso Leiva; Ferran Bejarano; Ermengol Sempere; Josep Basora; Vicente Palop; Marta Mengual; Jose Luis Beltran; Enric Aragonès; Guillem Lera; Silvia Folch; Josep Lluís Piñol; Magdalena Esteva; Miguel Roca; Arturo Arenas; María Del Mar Sureda; Francisco Campoamor; Francisca Fiol
Journal:  BMC Fam Pract       Date:  2011-04-20       Impact factor: 2.497

Review 2.  [Differential diagnosis of insomnia from other comorbid primary sleep disorders].

Authors:  Alex Ferré-Masó; Inmaculada Rodriguez-Ulecia; Iñaki García-Gurtubay
Journal:  Aten Primaria       Date:  2020-03-03       Impact factor: 1.137

3.  [Attitudes to insomnia by Primary Care physicians of Majorca (Spain)].

Authors:  Isabel Torrens; Marina Ortuño; Juan Ignacio Guerra; Magdalena Esteva; Patricia Lorente
Journal:  Aten Primaria       Date:  2015-11-02       Impact factor: 1.137

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.